Indeed, the widespread expression of AR in tumors is key to assess the PCa progression and treatment outcomes, and the majority of PCa tumors (80-90%) rely on androgen for their growth and survival [32, 33]. The gene discussed is AR; the disease is posterior cortical atrophy.